Morgan Stanley Keeps Their Buy Rating on Thermo Fisher (TMO)
I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst Kallum Titchmarsh maintained a Buy rating on Thermo Fisher (TMO) with a $620 price target. This follows a recent Buy from Deutsche Bank, while Bernstein had previously initiated coverage with a Hold rating.
Morgan Stanley analyst Kallum Titchmarsh maintained a Buy rating on Thermo Fisher today and set a price target of $620.00.
55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Titchmarsh covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Charles River Labs, and Guardant Health. According to TipRanks, Titchmarsh has an average return of 4.3% and a 50.00% success rate on recommended stocks.
In addition to Morgan Stanley, Thermo Fisher also received a Buy from Deutsche Bank ‘s Justin Bowers in a report issued yesterday. However, on June 25, Bernstein initiated coverage with a Hold rating on Thermo Fisher (NYSE: TMO).